LFWD (Lifeward) Total Equity: $6.29 Mil (As of Mar. 2026)


LFWD Lifeward Ltd LFWD
56 GF Score
Price $6.87
GF Value $13.73
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Lifeward Total Equity?

Lifeward LFWD -0.94% 56 Total Equity is $6.29 Mil as of Mar. 2026. GuruFocus rates LFWD with a GF Score™ of 56/100 and a GF Value™ of $13.73 (Possible Value Trap). The stock has 6 warning signs investors should review.

Lifeward's total equity for the quarter that ended in Mar. 2026 was $6.29 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Lifeward Total Equity Historical Data

* Premium members only.

The historical data trend for Lifeward's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifeward Total Equity Chart

Lifeward Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.38 68.17 46.51 18.85 8.41

Lifeward Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.46 15.11 12.76 8.41 6.29
LFWD
56GF Score
Lifeward Ltd LFWD
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifeward Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lifeward's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=22.9-14.492
=8.41

Lifeward's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=33.419-27.128
=6.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $6.29 Mil mean?
Lifeward (LFWD) has a Total Equity of $6.29 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Lifeward and its competitors.
Is Lifeward's Total Equity too high?
Lifeward's current Total Equity is $6.29 Mil. Overall, Lifeward has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifeward's Total Equity compare to GTHP and VNRX?
Lifeward's Total Equity of $6.29 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Lifeward and its competitors. Lifeward's current Total Equity is $6.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifeward stock overvalued right now?
Based on GuruFocus' analysis, Lifeward (LFWD) is currently considered Possible Value Trap. The stock's GF Value™ is $13.73, compared to a current price of $6.87 — trading 50% below its estimated fair value. The current Total Equity is $6.29 Mil. Lifeward's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Lifeward (LFWD), the current Total Equity is $6.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifeward (LFWD) Overvalued in 2026?

Based on GuruFocus' analysis, Lifeward stock appears to be undervalued. The current stock price of $6.87 is trading 50% below its estimated GF Value™ of $13.73. GuruFocus considers Lifeward to be Possible Value Trap.

Key valuation signals for LFWD:

  • Total Equity: $6.29 Mil
  • GF Value™: $13.73 vs. price of $6.87 (50% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the LFWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifeward Business Description

Address 2 Cabot Road, Hudson, MA, USA, 01749
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
56GF Score

Get the complete analysis for LFWD

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.87
Price
$13.73
GF Value